Clinical Trial Update: Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated abiraterone acetate in postmenopausal women with advanced or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Cancer Research UK | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED